Deutsche Bank’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-10,768
| Closed | -$248K | – | 4718 |
|
|
2020
Q4 | $248K | Buy |
10,768
+2,886
| +37% | +$66.5K | ﹤0.01% | 3304 |
|
|
2020
Q3 | $80K | Buy |
7,882
+688
| +10% | +$6.98K | ﹤0.01% | 3596 |
|
|
2020
Q2 | $107K | Buy |
7,194
+2,151
| +43% | +$32K | ﹤0.01% | 3353 |
|
|
2020
Q1 | $61K | Buy |
5,043
+2,468
| +96% | +$29.9K | ﹤0.01% | 3393 |
|
|
2019
Q4 | $40K | Buy |
2,575
+516
| +25% | +$8.02K | ﹤0.01% | 3942 |
|
|
2019
Q3 | $25K | Buy |
+2,059
| New | +$25K | ﹤0.01% | 4081 |
|